Sec. 761. Inclusion of exposure to perfluoroalkyl and polyfluoroalkyl substances as component of periodic health assessments
575 words·~3 min read·
/bill/117/hr/7900/pcs/section-761A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Each Secretary concerned shall ensure that any periodic health assessment provided to a member of the Armed Forces includes an evaluation of whether the member has been— based or stationed at a military installation identified by the Secretary concerned as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation; or exposed to such substances, including by evaluating any information in the health record of the member.
Section 1145(a)(5) of title 10, United States Code is amended by adding at the end the following new subparagraph: The Secretary concerned shall ensure that each physical examination of a member under subparagraph
(A)includes an assessment of whether the member was— based or stationed at a military installation identified by the Secretary concerned as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation; or exposed to such substances, including by assessing any information in the health record of the member. . Section 1074f(b)(2) of title 10, United States Code, is amended by adding at the end the following new subparagraph: An assessment of whether the member was— based or stationed at a military installation identified by the Secretary concerned as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation; or exposed to such substances, including by assessing any information in the health record of the member. If a covered evaluation of a member of the Armed Forces results in a positive determination of potential exposure to perfluoroalkyl substances or polyfluoroalkyl substances, the Secretary concerned shall provide to that member, during the covered evaluation, blood testing to determine and document potential exposure to such substances. The results of blood testing of a member of the Armed Forces conducted under subparagraph
(A)shall be included in the health record of the member. Not later than one year after the date of the enactment of this Act, the Secretary of Defense shall submit to the Committees on Armed Services of the House of Representatives and the Senate a plan, consistent with Department of Defense Instruction 6055.05 (or such successor instruction), to track and analyze, including through the identification and analysis of trends, the results of blood testing results provided pursuant to the paragraph
(1)or under section 707 of the National Defense Authorization Act for Fiscal Year 2020 ( Public Law 116–92 ; 133 Stat. 1441; 10 U.S.C. 1074m note). Not later than two years after the date of the enactment of this Act, and annually thereafter, the Secretary shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report containing a summary of the results of blood testing provided pursuant to paragraph (1), at a Department of Defense-wide level. In this section: The term covered evaluation means— a periodic health assessment conducted in accordance with subsection (a); a separation history and physical examination conducted under section 1145(a)(5) of title 10, United States Code, as amended by subsection (b); or a deployment assessment conducted under section 1074f(b)(2) of such title, as amended by subsection (c). The term Secretary concerned has the meaning given such term in section 101 of title 10, United States Code.
Connectionstraces to 2
Traces to 2 documents
1 reference not yet in our index
- 133 Stat. 1441
Citation graph
cites case law
Sec. 761
Inclusion of exposure to perfluoroalkyl and polyfluoroalkyl substances as component of periodic health assessments
Stat.133 Stat. 1441
Cites 3Cited by 0 across 0 sources